New and emerging regulators of intestinal lipoprotein secretion. [electronic resource]
Producer: 20141211Description: 608-615 p. digitalISSN:- 1879-1484
- Animals
- Apolipoprotein B-100 -- physiology
- Apolipoprotein B-48 -- physiology
- Atherosclerosis -- etiology
- Bile Acids and Salts -- metabolism
- Cholesterol -- metabolism
- Chylomicrons -- metabolism
- Clinical Trials as Topic
- Diabetes Mellitus, Type 2 -- blood
- Dietary Carbohydrates -- pharmacology
- Dietary Fats -- pharmacology
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Drug Evaluation, Preclinical
- Dyslipidemias -- etiology
- Exenatide
- Fatty Acids, Nonesterified -- blood
- Glucagon-Like Peptide 1 -- physiology
- Glucagon-Like Peptide 2 -- physiology
- Glucagon-Like Peptide-1 Receptor
- Humans
- Incretins -- physiology
- Insulin -- physiology
- Insulin Resistance -- physiology
- Intestine, Small -- metabolism
- Lipoproteins -- metabolism
- Microbiota
- Peptides -- pharmacology
- Receptors, Glucagon -- antagonists & inhibitors
- Resveratrol
- Secretory Rate
- Stilbenes -- pharmacology
- Triglycerides -- blood
- Venoms -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.